FDA Inspection
Wells Pharma of Houston LLCWells Pharma of Houston LLC – FDA Inspection, Jun 17, 2021
Record Details
This FDA Inspection record concerns Wells Pharma of Houston LLC, with an inspection on June 17, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Wells Pharma of Houston LLC
- Inspection Date
- June 17, 2021
- Product Type
- Drugs
View Company Profile
ID · 08c48720-4f39-4c03-97bb-5fc4b9adc1ed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1144681
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Wells Pharma of Houston LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 13, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| March 28, 2025 | OAI | Dallas District Office | Drug Quality Assurance |
| December 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Wells Pharma of Houston LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.